Albuquerque-based company lands patent for novel Alzheimer’s technology

The approval is for a "method patent," said Kristina Trujillo, TNeuroPharma's CEO. It's licensed exclusively to TNeuroPharma for the company's method of detecting T-cells in patients to diagnose and treat Alzheimer's.

West Oakland proposal with 1,038 apartments and no parking sparks backlash

Louisville apartment complex receives $750K grant for solar infrastructure

Phil Knight, Tim Boyle, CRE heavyweights invest $700K in new ballot initiative to amend M110

A woman of influence: Julia Nordgren — pediatrician, chef, author

Photos: Harper’s Steakhouse opens in downtown Nashville

Scottsdale-based Business Warrior uplists on Over The Counter market

CBF Morning Run: A magical night at the inaugural Women of Influence Awards

Almost Friday Sporting Club sets opening date in downtown Nashville

Albuquerque-based company lands patent for novel Alzheimer’s technology

Previous Medical Mutual is leaving downtown Cleveland headquarters

Next Business Coalition on Health hits 10th anniversary with 50 members, 1.5 million covered lives

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Housing Trust makes second large loan to an affordable housing project in the Diridon area

Nurses at Baltimore hospital file unfair labor charges amid union push

North Carolina REIT purchases Germantown medical office building

Minnesota Rubber and Plastics sold for $950 million

Readers name The Chive winner of Austin’s Coolest Offices contest

Schnitzer Properties buys more land for Metro Air Park project

MENU

FirstStar Group

More Stories

Vestavia Hills project could include Baumhower’s Victory Grille